Axsome Therapeutics (AXSM) Asset Utilization Ratio (2022 - 2026)

Axsome Therapeutics has disclosed Asset Utilization Ratio across 5 years of filings, most recently posting 1.01 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 1.01, up 87.33% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.01 (up 87.33% YoY), and the FY2025 annual result was 1.01, up 52.18% from the prior year.
• Asset Utilization Ratio came in at 1.01 for Q1 2026 at Axsome Therapeutics, up from 0.94 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 1.01 in Q1 2026 to a low of 0.1 in Q3 2022.
• The 5-year median for Asset Utilization Ratio is 0.47 (2024), against an average of 0.51.
• Across the five-year window, Asset Utilization Ratio surged 273.01% in 2023 and increased 4.0% in 2024, its largest moves.
• Axsome Therapeutics' Asset Utilization Ratio stood at 0.15 in 2022, then surged by 204.91% to 0.46 in 2023, then rose by 4.0% to 0.47 in 2024, then soared by 98.51% to 0.94 in 2025, then increased by 7.42% to 1.01 in 2026.
• The last three Asset Utilization Ratio figures came in at 1.01 (Q1 2026), 0.94 (Q4 2025), and 0.68 (Q3 2025), per Business Quant data.